Literature DB >> 29625827

A sofosbuvir-based quadruple regimen is highly effective in HCV type 4-infected Egyptian patients with DAA treatment failure.

Adel Abdel-Moneim1, Alaa Aboud2, Mohamed Abdel-Gabbar3, Mohamed I Zanaty4, Mohamed Ramadan3.   

Abstract

Entities:  

Keywords:  Chronic hepatitis C; Daclatasvir; Retreatment; Ribavirin; Simeprevir; Sofosbuvir

Mesh:

Substances:

Year:  2018        PMID: 29625827     DOI: 10.1016/j.jhep.2018.03.010

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  5 in total

1.  The outcome of re-treatment of relapsed hepatitis C virus infection in a resource-limited setting.

Authors:  Gina Gamal Naguib; Tari George Michael; Yehia Elshazly; Maha Magdy Wahdan; Aya Mostafa; Ossama Ashraf Ahmed; Hany Dabbous; Heba Ismail Saad Aly; Mohamed Kamal Shaker; Hosam Samir Elbaz; Magdy El-Serafy; Wahid Doss; Sherief Abd-Elsalam; Manal Hamdy El-Sayed
Journal:  Virusdisease       Date:  2021-07-27

2.  Efficacy and safety of sofosbuvir plus daclatasvir with or without ribavirin: large real-life results of patients with chronic hepatitis C genotype 4.

Authors:  Adel Abdel-Moneim; Alaa Aboud; Mohamed Abdel-Gabaar; Mohamed I Zanaty; Mohamed Ramadan
Journal:  Hepatol Int       Date:  2018-05-12       Impact factor: 6.047

Review 3.  Treatment of hepatitis C virus genotype 4 in the DAA era.

Authors:  Antonio Di Biagio; Lucia Taramasso; Giovanni Cenderello
Journal:  Virol J       Date:  2018-11-22       Impact factor: 4.099

4.  Deep-sequencing study of HCV G4a resistance-associated substitutions in Egyptian patients failing DAA treatment.

Authors:  Fatma Amer; Monkez M Yousif; Noha M Hammad; Damir Garcia-Cehic; Josep Gregori; Ariadna Rando-Segura; Leonardo Nieto-Aponte; Juan Ignacio Esteban; Francisco Rodriguez-Frias; Josep Quer
Journal:  Infect Drug Resist       Date:  2019-09-10       Impact factor: 4.003

5.  Sofosbuvir in combination with ribavirin or simeprevir: real-life study of patients with hepatitis C genotype 4.

Authors:  Adel Abdel-Moneim; Alaa Aboud; Mohamed Abdel-Gabbar; Mohamed I Zanaty; Amr A Abd Elbary; Mohamed Ramadan
Journal:  Ann Gastroenterol       Date:  2018-11-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.